Answers are grounded in this paper and cite their sources.
Type 1 diabetes is increasingly recognised as a heterogeneous disease with substantial variability in risk, progression, metabolic control and complications. Biological sex is a critical but understudied contributor to this heterogeneity. This review synthesises epidemiological, mechanistic and clinical evidence that sex influences multiple dimensions of type 1 diabetes, including disease epidemiology, the underlying pathophysiology, clinical presentation, complications and treatment responses. These effects are highly dynamic and shaped by interactions among age, hormonal transitions, genetic susceptibility and environmental exposures. Recognition of sex-specific heterogeneity has important implications for screening, risk prediction, monitoring and therapeutic development. We propose that future type 1 diabetes research moves beyond treating sex solely as a covariate and instead incorporates appropriately powered sex-stratified analyses and hormonal context to determine when sex meaningfully modifies disease risk, progression or treatment response.
No takes yet. Share an insight, caveat, or question.
Ferrat et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: